The pandemic was a boon for NRT cessation aids, with many people trying to give up smoking as COVID-19 put the spotlight on lung health. In 2022, the environment has returned to pre pandemic times and the performance of NRT cessation aids is expected to be stable. There is expected to an increase in current value, due to the inflation stemming from the energy crisis caused by the war in Ukraine. While value growth is expected to be up, volume sales are expected to on par with the previous year.
The NRT Smoking Cessation Aids in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The NRT Smoking Cessation Aids in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
NRT SMOKING CESSATION AIDS IN DENMARKKEY DATA FINDINGSCONSUMER HEALTH IN DENMARKDISCLAIMERDEFINITIONS
2022 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY INDICATORS
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES